MSH3 mutations have been mainly linked to endometrial cancer, but there are reports of its relationship with inflammatory processes, such as ulcerative colitis and Crohn’s disease, which considerably increase the likelihood of CRC development [54,55]. Here, MSH3 is linked to colorectal carcinoma.